Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
26
Number of overlapping holdings
20.5%
% of BMED's 140 holdings also in BBP
42.6%
% of BBP's 65 holdings also in BMED
Overlap by Weight
Sector Drift (BMED minus BBP)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in BMED |
Weight in BBP |
Overlap | |
|---|---|---|---|---|
 |
ALNYLAM PHARMACEUTICALS INC | 2.6% | 2.1% | 2.1% |
|
AMGEN INC | 2.5% | 1.6% | 1.6% |
|
BIOMARIN PHARMACEUTICAL INC | 1.9% | 1.5% | 1.5% |
|
RHYTHM PHARMACEUTICALS, INC. | 1.4% | 1.6% | 1.4% |
|
NEUROCRINE BIOSCIENCES INC | 1.3% | 1.6% | 1.3% |
Position Highlights (Non-Overlapping Exposures)
BMED Overweight Relative to BBP
|
BOSTON SCIENTIFIC CORP | 3.7% |
|
AMERISOURCEBERGEN CORP | 3.4% |
|
INTUITIVE SURGICAL INC | 2.8% |
 |
ARGENX SE ADR | 2.4% |
 |
METTLER-TOLEDO INTERNATIONAL | 2.4% |
|
WEST PHARMACEUTICAL SERVICES | 2.3% |
|
DANAHER CORP | 2.0% |
|
BIO-TECHNE CORPORATION | 1.9% |
|
QIAGEN NV | 1.8% |
|
MCKESSON CORP | 1.7% |
BMED Underweight Relative to BBP
|
MIRUM PHARMACEUTICALS, INC. | -2.4% |
|
TRAVERE THERAPEUTICS, INC. | -2.0% |
|
LIGAND PHARMACEUTICALS-CL B | -1.9% |
|
LEXICON PHARMACEUTICALS, INC. | -1.9% |
|
ACADIA PHARMACEUTICALS INC | -1.9% |
|
BIOCRYST PHARMACEUTICALS INC | -1.8% |
|
DAY ONE BIOPHARMACEUTICALS, INC. | -1.8% |
|
TG THERAPEUTICS INC | -1.8% |
|
ADMA BIOLOGICS, INC. | -1.8% |
|
GILEAD SCIENCES INC | -1.8% |